Article ID Journal Published Year Pages File Type
4152302 Current Paediatrics 2006 5 Pages PDF
Abstract

SummaryNewborn screening for phenylketonuria has been available since the early 1960s. Advances in technology such as the introduction of tandem mass spectrometry have increased the number of conditions we are now able to screen for. More recently the possibility of genetic profiling of the newborn has been raised. This article looks at these changes and discusses some of the ethical issues that they raise.

Related Topics
Health Sciences Medicine and Dentistry Perinatology, Pediatrics and Child Health
Authors
,